• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

周期性回归协变量消除了疟原虫恶性疟原虫中与菌株特异性药物反应相关的周期性发育基因表达的主要混杂影响。

Cyclical regression covariates remove the major confounding effect of cyclical developmental gene expression with strain-specific drug response in the malaria parasite Plasmodium falciparum.

机构信息

Eck Institute for Global Health, Department of Biological Sciences, University of Notre Dame, IN, Notre Dame, USA.

出版信息

BMC Genomics. 2022 Mar 5;23(1):180. doi: 10.1186/s12864-021-08281-y.

DOI:10.1186/s12864-021-08281-y
PMID:35247977
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8897900/
Abstract

BACKGROUND

The cyclical nature of gene expression in the intraerythrocytic development cycle (IDC) of the malaria parasite, Plasmodium falciparum, confounds the accurate detection of specific transcriptional differences, e.g. as provoked by the development of drug resistance. In lab-based studies, P. falciparum cultures are synchronized to remove this confounding factor, but the rapid detection of emerging resistance to artemisinin therapies requires rapid analysis of transcriptomes extracted directly from clinical samples. Here we propose the use of cyclical regression covariates (CRC) to eliminate the major confounding effect of developmentally driven transcriptional changes in clinical samples. We show that elimination of this confounding factor reduces both Type I and Type II errors and demonstrate the effectiveness of this approach using a published dataset of 1043 transcriptomes extracted directly from patient blood samples with different patient clearance times after treatment with artemisinin.

RESULTS

We apply this method to two publicly available datasets and demonstrate its ability to reduce the confounding of differences in transcript levels due to misaligned intraerythrocytic development time. Adjusting the clinical 1043 transcriptomes dataset with CRC results in detection of fewer functional categories than previously reported from the same data set adjusted using other methods. We also detect mostly the same functional categories, but observe fewer genes within these categories. Finally, the CRC method identifies genes in a functional category that was absent from the results when the dataset was adjusted using other methods. Analysis of differential gene expression in the clinical data samples that vary broadly for developmental stage resulted in the detection of far fewer transcripts in fewer functional categories while, at the same time, identifying genes in two functional categories not present in the unadjusted data analysis. These differences are consistent with the expectation that CRC reduces both false positives and false negatives with the largest effect on datasets from samples with greater variance in developmental stage.

CONCLUSIONS

Cyclical regression covariates have immediate application to parasite transcriptome sequencing directly from clinical blood samples and to cost-constrained in vitro experiments.

摘要

背景

疟原虫(Plasmodium falciparum)在红细胞内发育周期(IDC)中的基因表达呈周期性,这使得准确检测特定的转录差异变得复杂,例如由耐药性的发展引起的差异。在实验室基础的研究中,通过同步化疟原虫培养来消除这种混杂因素,但快速检测到青蒿素疗法的耐药性的出现,需要对直接从临床样本中提取的转录组进行快速分析。在这里,我们提出使用周期性回归协变量(CRC)来消除临床样本中由发育驱动的转录变化的主要混杂效应。我们证明消除这种混杂因素可以减少 I 型和 II 型错误,并使用从接受青蒿素治疗后不同清除时间的患者血液样本中直接提取的 1043 个转录组的已发表数据集证明了这种方法的有效性。

结果

我们将该方法应用于两个公开数据集,并证明它能够减少由于红细胞内发育时间未对准导致的转录水平差异的混杂。使用 CRC 调整临床 1043 个转录组数据集的结果比以前使用其他方法从同一数据集调整后的结果检测到的功能类别更少。我们还检测到了大多数相同的功能类别,但在这些类别中观察到的基因较少。最后,CRC 方法在使用其他方法调整数据集时未检测到的功能类别中识别出基因。对临床数据样本进行广泛的发育阶段差异分析,结果仅在少数功能类别中检测到较少的转录物,同时在未调整数据分析中未检测到的两个功能类别中鉴定出基因。这些差异与 CRC 减少假阳性和假阴性的预期一致,对发育阶段差异较大的样本数据集的影响最大。

结论

周期性回归协变量可立即应用于直接从临床血液样本中进行寄生虫转录组测序,以及成本受限的体外实验。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1e4/8897900/f9cf7f9b774a/12864_2021_8281_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1e4/8897900/44d1d062ee2b/12864_2021_8281_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1e4/8897900/5b5feed6ef5a/12864_2021_8281_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1e4/8897900/433ef91e8415/12864_2021_8281_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1e4/8897900/f9cf7f9b774a/12864_2021_8281_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1e4/8897900/44d1d062ee2b/12864_2021_8281_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1e4/8897900/5b5feed6ef5a/12864_2021_8281_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1e4/8897900/433ef91e8415/12864_2021_8281_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1e4/8897900/f9cf7f9b774a/12864_2021_8281_Fig4_HTML.jpg

相似文献

1
Cyclical regression covariates remove the major confounding effect of cyclical developmental gene expression with strain-specific drug response in the malaria parasite Plasmodium falciparum.周期性回归协变量消除了疟原虫恶性疟原虫中与菌株特异性药物反应相关的周期性发育基因表达的主要混杂影响。
BMC Genomics. 2022 Mar 5;23(1):180. doi: 10.1186/s12864-021-08281-y.
2
The volatilome signatures of Plasmodium falciparum parasites during the intraerythrocytic development cycle in vitro under exposure to artemisinin drug.在暴露于青蒿素药物的情况下,体外疟原虫红内期发育周期中的挥发组特征。
Sci Rep. 2023 Nov 17;13(1):20167. doi: 10.1038/s41598-023-46416-1.
3
Local emergence in Amazonia of C580Y mutants associated with artemisinin resistance.在亚马逊地区出现与青蒿素耐药性相关的 C580Y 突变体。
Elife. 2020 May 12;9:e51015. doi: 10.7554/eLife.51015.
4
Role of Plasmodium falciparum Kelch 13 Protein Mutations in P. falciparum Populations from Northeastern Myanmar in Mediating Artemisinin Resistance.恶性疟原虫Kelch13 蛋白突变在缅甸东北部地区恶性疟原虫种群中对青蒿素耐药性的介导作用。
mBio. 2020 Feb 25;11(1):e01134-19. doi: 10.1128/mBio.01134-19.
5
Plasmodium berghei K13 Mutations Mediate Artemisinin Resistance That Is Reversed by Proteasome Inhibition.疟原虫伯氏疟原虫 K13 突变介导的青蒿素耐药性可被蛋白酶体抑制逆转。
mBio. 2020 Nov 10;11(6):e02312-20. doi: 10.1128/mBio.02312-20.
6
Expression Patterns of Plasmodium falciparum Clonally Variant Genes at the Onset of a Blood Infection in Malaria-Naive Humans.疟原虫无性系变异基因在人类初次感染疟疾时的血液感染中的表达模式。
mBio. 2021 Aug 31;12(4):e0163621. doi: 10.1128/mBio.01636-21. Epub 2021 Aug 3.
7
Artemisinin Resistance and Stage Dependency of Parasite Clearance in Falciparum Malaria.青蒿素耐药性和恶性疟原虫清除的阶段依赖性。
J Infect Dis. 2019 Apr 16;219(9):1483-1489. doi: 10.1093/infdis/jiy673.
8
A Variant PfCRT Isoform Can Contribute to Resistance to the First-Line Partner Drug Piperaquine.一种变异的疟原虫氯喹抗性转运蛋白(PfCRT)异构体可能导致对一线联合用药磷酸哌喹产生耐药性。
mBio. 2017 May 9;8(3):e00303-17. doi: 10.1128/mBio.00303-17.
9
In vitro selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants by artemisinin.青蒿素对恶性疟原虫Pfcrt和Pfmdr1变体的体外筛选
Malar J. 2016 Jul 22;15(1):381. doi: 10.1186/s12936-016-1443-y.
10
K13 Mutations Differentially Impact Ozonide Susceptibility and Parasite Fitness .K13突变对臭氧敏感性和寄生虫适应性有不同影响。
mBio. 2017 Apr 11;8(2):e00172-17. doi: 10.1128/mBio.00172-17.

引用本文的文献

1
Molecular Cellular Parasitology: The Decades and Challenges Ahead.分子细胞寄生虫学:未来几十年及挑战
Front Parasitol. 2022 Jul 7;1:963515. doi: 10.3389/fpara.2022.963515. eCollection 2022.

本文引用的文献

1
Plasmodium berghei K13 Mutations Mediate Artemisinin Resistance That Is Reversed by Proteasome Inhibition.疟原虫伯氏疟原虫 K13 突变介导的青蒿素耐药性可被蛋白酶体抑制逆转。
mBio. 2020 Nov 10;11(6):e02312-20. doi: 10.1128/mBio.02312-20.
2
Estimation of parasite age and synchrony status in Plasmodium falciparum infections.疟原虫感染中寄生虫年龄和同步状态的估计。
Sci Rep. 2020 Jul 2;10(1):10925. doi: 10.1038/s41598-020-67817-6.
3
An intrinsic oscillator drives the blood stage cycle of the malaria parasite .内在振荡器驱动疟原虫的血期循环。
Science. 2020 May 15;368(6492):754-759. doi: 10.1126/science.aba4357.
4
A Kelch13-defined endocytosis pathway mediates artemisinin resistance in malaria parasites.Kelch13 定义的内吞途径介导疟原虫对青蒿素的耐药性。
Science. 2020 Jan 3;367(6473):51-59. doi: 10.1126/science.aax4735.
5
Decreased K13 Abundance Reduces Hemoglobin Catabolism and Proteotoxic Stress, Underpinning Artemisinin Resistance.疟原虫 K13 丰度降低可减少血红蛋白代谢和蛋白毒性应激,为青蒿素耐药提供了基础。
Cell Rep. 2019 Nov 26;29(9):2917-2928.e5. doi: 10.1016/j.celrep.2019.10.095.
6
Improvement of Asparagine Ethylenediamines as Anti-malarial -Selective Proteasome Inhibitors.作为抗疟选择性蛋白酶体抑制剂的天冬酰胺乙二胺的改良。
J Med Chem. 2019 Jul 11;62(13):6137-6145. doi: 10.1021/acs.jmedchem.9b00363. Epub 2019 Jun 20.
7
Covalent Plasmodium falciparum-selective proteasome inhibitors exhibit a low propensity for generating resistance in vitro and synergize with multiple antimalarial agents.共价型疟原虫选择性蛋白酶体抑制剂在体外产生耐药性的倾向较低,并与多种抗疟药物具有协同作用。
PLoS Pathog. 2019 Jun 6;15(6):e1007722. doi: 10.1371/journal.ppat.1007722. eCollection 2019 Jun.
8
The past, present and future of anti-malarial medicines.抗疟药物的过去、现在和未来。
Malar J. 2019 Mar 22;18(1):93. doi: 10.1186/s12936-019-2724-z.
9
Genome-Wide Transcriptional Responses of to Antibiotics.[细菌名称]对抗生素的全基因组转录反应 (注:原文中“of”后面缺少具体的细菌名称等相关信息)
Front Microbiol. 2019 Feb 20;10:249. doi: 10.3389/fmicb.2019.00249. eCollection 2019.
10
The origins of malaria artemisinin resistance defined by a genetic and transcriptomic background.疟原虫青蒿素耐药性的起源由遗传和转录组背景定义。
Nat Commun. 2018 Dec 4;9(1):5158. doi: 10.1038/s41467-018-07588-x.